Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Shivering is one of the most frequent complications occurring during or after spinal anesthesia with many side effects. The aim of the present study was to compare between two different doses of ondansetron for anti-shivering effect
Shivering is one of the most frequent complications occurring during or after spinal anesthesia, it affects about 40%-60 % of patients under spinal anesthesia. Intra and Post spinal shivering is distressing for the patients and anesthetist. Shivering may aggravate medical conditions in patients with limited cardiac or respiratory functions. It increases tissue oxygen demand many folds which in turn leads to increase the load on respiratory and cardiac systems to cope with increased aerobic metabolism. Shivering interferes with good patient monitoring by causing artifacts of electrocardiography, invasive and non-invasive blood pressure, pulse oximetry, etc... . Postoperatively shivering may cause discomfort to the patient, increases wound pain by stretching incision, increase the incidence of bleeding and infection.
We aim to compare the prophylactic use of two different doses of ondansetron on the incidence of shivering after spinal anesthesia in patients scheduled for lower limb surgery.
The primary outcome was percentage of patients suffering from shivering after spinal anesthesia, secondary outcomes include any side effects related to both doses.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| normal saline | Active Comparator | patients received normal saline for prevention of shivering during spinal anesthesia |
|
| ondansetron 4MG | Active Comparator | patients received 4 mg of ondansetron for prevention of spinal shivering |
|
| ondansetron 8MG | Active Comparator | patients received 8 mg of ondansetron for prevention of spinal shivering |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Normal saline | Drug | normal saline used for prevention of spinal shivering |
|
| Measure | Description | Time Frame |
|---|---|---|
| incidence of shivering | Incidence of shivering among patients in both groups | for 24 hours after spinal anesthesia |
| Measure | Description | Time Frame |
|---|---|---|
| Axillary temperature | patient temperature measured from axillary site | for 24 hours after spinal anesthesia |
| core temperature | patient temperature measured from tympanic site |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000077330 | Saline Solution |
| D017294 | Ondansetron |
| ID | Term |
|---|---|
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ondansetron 4 MG | Drug | ondansetron 4 MG used for prevention of spinal shivering |
|
|
| Ondansetron 8mg | Drug | ondansetron 8 MG used for prevention of spinal shivering |
|
|
| for 24 hours after spinal anesthesia |
| incidence of hypotension | Incidence of hypotension between patients in both groups | for 24 hours after spinal anesthesia |
| incidence of nausea and vomiting | Incidence of nausea and vomiting among patients in both groups | for 24 hours after spinal anesthesia |
| D007093 |
| Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D002227 | Carbazoles |
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006575 | Heterocyclic Compounds, 3-Ring |